Maher K Gandhi

Maher K Gandhi

UNVERIFIED PROFILE

Are you Maher K Gandhi?   Register this Author

Register author
Maher K Gandhi

Maher K Gandhi

Publications by authors named "Maher K Gandhi"

Are you Maher K Gandhi?   Register this Author

65Publications

1054Reads

50Profile Views

Biology and therapy of primary mediastinal B-cell lymphoma: current status and future directions.

Br J Haematol 2019 Apr 10;185(1):25-41. Epub 2019 Feb 10.

Blood Cancer Research Group, Mater Research, University of Queensland, Translational Research Institute, Brisbane, QLD, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.15778DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6594147PMC
April 2019

Simple, rapid and inexpensive typing of common HLA class I alleles for immunological studies.

J Immunol Methods 2019 Feb 8;465:72-76. Epub 2018 Dec 8.

University of Queensland Diamantina Institute, The University of Queensland, Translational Research Institute, Woolloongabba, Queensland, Australia. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00221759183020
Publisher Site
http://dx.doi.org/10.1016/j.jim.2018.12.002DOI Listing
February 2019

Epigenetically reprogrammed methylation landscape drives the DNA self-assembly and serves as a universal cancer biomarker.

Nat Commun 2018 12 4;9(1):4915. Epub 2018 Dec 4.

Center for Personalised Nanomedicine, Australian Institute for Bioengineering and Nanotechnology (AIBN), Corner of College and Cooper Roads (Bldg 75), The University of Queensland, Brisbane, QLD, 4072, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41467-018-07214-wDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6279781PMC
December 2018

B cell lymphoma progression promotes the accumulation of circulating Ly6Clo monocytes with immunosuppressive activity.

Oncoimmunology 2018 18;7(2):e1393599. Epub 2017 Dec 18.

The University of Queensland Diamantina Institute, The University of Queensland, Translational Research Institute, Brisbane, Queensland, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/2162402X.2017.1393599DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5749670PMC
December 2017

Whole blood EBV-DNA: A surrogate for immune dysfunction in aggressive lymphoma?

Leuk Lymphoma 2016 8;57(3):507-8. Epub 2015 Oct 8.

a University of Queensland Diamantina Institute, Translational Research Institute, University of Queensland , Australia and.

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.3109/10428194.2015.1
Publisher Site
http://dx.doi.org/10.3109/10428194.2015.1087522DOI Listing
August 2016

Dielectrophoretic Microfluidic Chip Enables Single-Cell Measurements for Multidrug Resistance in Heterogeneous Acute Myeloid Leukemia Patient Samples.

Anal Chem 2016 06 17;88(11):5680-8. Epub 2016 May 17.

Terry Fox Laboratory, BC Cancer Agency , 675 West 10th Avenue, Vancouver, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/acs.analchem.5b04446DOI Listing
June 2016

Deregulated JAK/STAT signalling in lymphomagenesis, and its implications for the development of new targeted therapies.

Blood Rev 2015 Nov 11;29(6):405-15. Epub 2015 Jun 11.

University of Queensland Diamantina Institute, University of Queensland, Translational Research Institute, Brisbane, Australia; Department of Haematology, Princess Alexandra Hospital, Brisbane, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.blre.2015.06.002DOI Listing
November 2015

Cessation of immunosuppression during chemotherapy for post-transplant lymphoproliferative disorders in renal transplant patients.

Nephrol Dial Transplant 2015 Oct 18;30(10):1774-9. Epub 2015 Jul 18.

Department of Haematology, Pathology Queensland and Cancer Services, Princess Alexandra Hospital, Brisbane, Australia School of Medicine, University of Queensland, Brisbane, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ndt/gfv260DOI Listing
October 2015

Ratios of T-cell immune effectors and checkpoint molecules as prognostic biomarkers in diffuse large B-cell lymphoma: a population-based study.

Lancet Haematol 2015 Oct 1;2(10):e445-55. Epub 2015 Oct 1.

University of Queensland Diamantina Institute, Translational Research Institute, University of Queensland, Brisbane, QLD, Australia; Princess Alexandra Hospital, Brisbane, QLD, Australia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2352-3026(15)00150-7DOI Listing
October 2015

HLA class I associations with EBV+ post-transplant lymphoproliferative disorder.

Transpl Immunol 2015 Mar 27;32(2):126-30. Epub 2015 Feb 27.

Blood Cancer Research Laboratory, University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia; Department of Haematology, Princess Alexandra Hospital, Brisbane, Australia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.trim.2015.02.005DOI Listing
March 2015

A multi-centre, single-arm, open-label study evaluating the safety and efficacy of fixed dose rituximab in patients with refractory, relapsed or chronic idiopathic thrombocytopenic purpura (R-ITP1000 study).

Br J Haematol 2014 Oct 11;167(2):243-51. Epub 2014 Jul 11.

Monash Medical Centre, Clayton, Vic., Australia; Australian Centre for Bloods Diseases, Monash University, Melbourne, Vic., Australia.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/bjh.13029
Publisher Site
http://dx.doi.org/10.1111/bjh.13029DOI Listing
October 2014

A new frontier in haematology - combining pharmacokinetic with pharmacodynamic factors to improve choice and dose of drug.

Br J Clin Pharmacol 2014 Aug;78(2):274-81

School of Medicine, University of Queensland, Princess Alexandra Hospital Campus, Woolloongabba, Australia; Translational Research Institute, Woolloongabba, Queensland, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bcp.12318DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4137820PMC
August 2014

In silico analyses reveal common cellular pathways affected by loss of heterozygosity (LOH) events in the lymphomagenesis of Non-Hodgkin's lymphoma (NHL).

BMC Genomics 2014 May 21;15:390. Epub 2014 May 21.

Genomics Research Centre, Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2164-15-390DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4041994PMC
May 2014

Plasma microRNA are disease response biomarkers in classical Hodgkin lymphoma.

Clin Cancer Res 2014 Jan 12;20(1):253-64. Epub 2013 Nov 12.

Authors' Affiliations: Clinical Immunohaematology Laboratory, QIMR Berghofer Medical Research Institute; Centre for Experimental Haematology, University of Queensland School of Medicine, Translational Research Institute; Department of Haematology, Princess Alexandra Hospital, Brisbane, Queensland; and Griffith University, Gold Coast, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-13-1024DOI Listing
January 2014

The Epstein-Barr virus microRNA BART11-5p targets the early B-cell transcription factor EBF1.

Am J Blood Res 2013 19;3(3):210-24. Epub 2013 Aug 19.

Clinical Immunohematology Laboratory, Queensland Institute of Medical Research Level 10, CBCRC Building, Herston Road, Brisbane, Queensland, 4006 ; Queensland University of Technology 60 Musk Avenue, Kelvin Grove Urban Village, Kelvin Grove, Queensland, 4059, Australia.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3755520PMC
September 2013

High-resolution loss of heterozygosity screening implicates PTPRJ as a potential tumor suppressor gene that affects susceptibility to Non-Hodgkin's lymphoma.

Genes Chromosomes Cancer 2013 May 23;52(5):467-79. Epub 2013 Jan 23.

Genomics Research Centre, Griffith Health Institute, Griffith University, Gold Coast, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/gcc.22044DOI Listing
May 2013

Serum CD163 and TARC as disease response biomarkers in classical Hodgkin lymphoma.

Clin Cancer Res 2013 Feb 5;19(3):731-42. Epub 2012 Dec 5.

Clinical Immunohaematology Laboratory, Queensland Institute of Medical Research (QIMR), Queensland, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-12-2693DOI Listing
February 2013

Back to basics: the complete blood cell count adds to the ability of immunohistochemistry in diffuse large B-cell lymphoma prognosis.

Leuk Lymphoma 2012 Nov 9;53(11):2097-8. Epub 2012 Jul 9.

Clinical Immunohaematology Laboratory, Queensland Institute of Medical Research , Brisbane, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2012.701297DOI Listing
November 2012

Expression profiling of Epstein-Barr virus-encoded microRNAs from paraffin-embedded formalin-fixed primary Epstein-Barr virus-positive B-cell lymphoma samples.

J Virol Methods 2012 Sep 16;184(1-2):46-54. Epub 2012 May 16.

Clinical Immunohaematology Laboratory, Queensland Institute of Medical Research, Brisbane, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jviromet.2012.05.005DOI Listing
September 2012

Tumor-specific but not nonspecific cell-free circulating DNA can be used to monitor disease response in lymphoma.

Am J Hematol 2012 Mar 27;87(3):258-65. Epub 2011 Dec 27.

Clinical Immunohaematology Laboratory, Queensland Institute of Medical Research, Brisbane, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.22252DOI Listing
March 2012

The KIR2DS2/DL2 genotype is associated with adult persistent/chronic and relapsed immune thrombocytopenia independently of FCGR3a-158 polymorphisms.

Blood Coagul Fibrinolysis 2012 Jan;23(1):45-50

Clinical Immunohaematology Laboratory, Queensland Institute of Medical Research, Brisbane, Queensland, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MBC.0b013e32834d7ce3DOI Listing
January 2012

Broad-spectrum immunosuppression by classless monocytes in non-Hodgkin's lymphoma.

Immunotherapy 2011 Jun;3(6):723-6

Clinical Immunohaematology Laboratory, Queensland Institute of Medical Research, 300 Herston Road, Herston, Queensland, 4006, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/imt.11.56DOI Listing
June 2011

Integrative genomic profiling reveals conserved genetic mechanisms for tumorigenesis in common entities of non-Hodgkin's lymphoma.

Genes Chromosomes Cancer 2011 May 8;50(5):313-26. Epub 2011 Feb 8.

Genomics Research Centre, Griffith Health Institute, Griffith University, QLD, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/gcc.20856DOI Listing
May 2011

Expansion of EBNA1-specific effector T cells in posttransplantation lymphoproliferative disorders.

Blood 2010 Sep 18;116(13):2245-52. Epub 2010 Jun 18.

Clinical Immunohaematology Laboratory and Australian Centre for Vaccine Development, Queensland Institute of Medical Research, 300 Herston Road, Brisbane, QLD 4006, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2010-03-274076DOI Listing
September 2010

Can a blood test monitor lymphoma?

Leuk Lymphoma 2010 Jun;51(6):957-9

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2010.487623DOI Listing
June 2010

Fulminant infectious mononucleosis and recurrent Epstein-Barr virus reactivation in an adolescent.

Clin Infect Dis 2010 Mar;50(6):e34-7

Clinical Immunohaematology Laboratory, Queensland Institute of Medical Research, Brisbane, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1086/650007DOI Listing
March 2010

High levels of BACH2 associated with lower levels of BCL2 transcript abundance in t(14;18)(q21;q34) translocation positive non-Hodgkin's lymphoma.

Leuk Res 2009 May 16;33(5):731-4. Epub 2008 Oct 16.

Genomics Research Centre, Griffith Institute for Health and Medical Research, Griffith University, Queensland 9726, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2008.09.007DOI Listing
May 2009

Epstein-Barr virus DNA as a biomarker for Epstein-Barr virus-positive lymphomas: are we there yet?

Leuk Lymphoma 2009 May;50(5):684-6

Clinical Immunohaematology Laboratory, Queensland Institute of Medical Research, Brisbane, Queensland, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428190902847716DOI Listing
May 2009

The role of Epstein-Barr virus in Richter syndrome.

Br J Haematol 2009 Feb 11;144(4):613; author reply 614-5. Epub 2008 Nov 11.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1365-2141.2008.07471.xDOI Listing
February 2009

Immunodeficiency-associated lymphomas.

Blood Rev 2008 Sep 5;22(5):261-81. Epub 2008 May 5.

Department of Haematology, Princess Alexandra Hospital, Ipswich Road, Brisbane, Queensland, 4102, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.blre.2008.03.009DOI Listing
September 2008

Methotrexate-associated mantle-cell lymphoma in an elderly man with myasthenia gravis.

Nat Clin Pract Oncol 2008 Apr 19;5(4):234-8. Epub 2008 Feb 19.

Princess Alexandra Hospital, Brisbane, Australia.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/ncponc1071
Publisher Site
http://dx.doi.org/10.1038/ncponc1071DOI Listing
April 2008

Galectin-1 mediated suppression of Epstein-Barr virus specific T-cell immunity in classic Hodgkin lymphoma.

Blood 2007 Aug 16;110(4):1326-9. Epub 2007 Apr 16.

Australian Centre for Vaccine Development, Tumor Immunology Laboratory, Division of Infectious Diseases and Immunology, Queensland Institute of Medical Research, Brisbane, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2007-01-066100DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1939905PMC
August 2007

Epstein-Barr virus T-cell immunity despite rituximab.

Br J Haematol 2007 Feb;136(4):628-32

EBV Biology Laboratory, Division of Infectious Diseases and Immunology, Queensland Institute of Medical Research, Brisbane, Queensland, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1365-2141.2006.06482.xDOI Listing
February 2007

Expression of LAG-3 by tumor-infiltrating lymphocytes is coincident with the suppression of latent membrane antigen-specific CD8+ T-cell function in Hodgkin lymphoma patients.

Blood 2006 Oct 6;108(7):2280-9. Epub 2006 Jun 6.

Tumor Immunology Laboratory, Division of Infectious Diseases and Immunology, Queensland Institute of Medical Research, Brisbane, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2006-04-015164DOI Listing
October 2006

Epstein-Barr virus-associated lymphomas.

Authors:
Maher K Gandhi

Expert Rev Anti Infect Ther 2006 Feb;4(1):77-89

Tumor Immunology Lab, Level I, CRC, QIMR, Brisbane, 4006, Queensland, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/14787210.4.1.77DOI Listing
February 2006

Plasma Epstein-Barr virus (EBV) DNA is a biomarker for EBV-positive Hodgkin's lymphoma.

Clin Cancer Res 2006 Jan;12(2):460-4

Tumour Immunology Laboratory, Division of Infectious Diseases and Immunology, Queensland Institute of Medical Research, Department of Haematology, Princess Alexandra Hospital, Brisbane, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-05-2008DOI Listing
January 2006

Viruses and lymphoma.

Pathology 2005 Dec;37(6):420-33

Tumour Immunology Laboratory, Queensland Institute of Medical Research, Brisbane, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/003130200500368303DOI Listing
December 2005

Regulation of clinical research.

Authors:
Maher K Gandhi

Clin Med (Lond) 2005 May-Jun;5(3):299

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4952220PMC
http://dx.doi.org/10.7861/clinmedicine.5-3-299DOI Listing
October 2005

Follicular lymphoma: time for a re-think?

Blood Rev 2005 May;19(3):165-78

Department of Haematology, Princess Alexandra Hospital, Brisbane, 4006 QLD, Australia.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S0268960X0400037
Publisher Site
http://dx.doi.org/10.1016/j.blre.2004.09.001DOI Listing
May 2005

Human cytomegalovirus: clinical aspects, immune regulation, and emerging treatments.

Lancet Infect Dis 2004 Dec;4(12):725-38

Tumour Immunology Laboratory at the Queensland Institute of Medical Research, Brisbane, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1473-3099(04)01202-2DOI Listing
December 2004

Epstein-Barr virus-associated Hodgkin's lymphoma.

Br J Haematol 2004 May;125(3):267-81

Department of Tumour Immunology, Division of Infectious Diseases and Immunology, Queensland Institute of Medical Research, Herston, Brisbane, Queensland, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1365-2141.2004.04902.xDOI Listing
May 2004

Human cytomegalovirus-specific immunity following haemopoietic stem cell transplantation.

Blood Rev 2003 Dec;17(4):259-64

Department of Haematology, University of Cambridge Clinical School, Cambridge, UK.

View Article

Download full-text PDF

Source
December 2003

Late diversification in the clonal composition of human cytomegalovirus-specific CD8+ T cells following allogeneic hemopoietic stem cell transplantation.

Blood 2003 Nov 17;102(9):3427-38. Epub 2003 Jul 17.

Department of Medicine, University of Cambridge Clinical School, Hills Rd, Cambridge, CB2 2QQ, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2002-12-3689DOI Listing
November 2003